JP Patent

JP5814467B2 — キナーゼ阻害剤としてのイミダゾ［１，２−ｂ］ピリダジン誘導体

Assigned to Daiichi Sankyo Co Ltd · Expires 2015-11-17 · 10y expired

What this patent protects

Patent listed against taletrectinib-adipate.

Drugs covered by this patent

taletrectinib-adipate (TALETRECTINIB ADIPATE)

Patent Metadata

Patent number: JP5814467B2
Jurisdiction: JP
Classification: —
Expires: 2015-11-17
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Sankyo Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.